Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2012
06/21/2012WO2012081604A1 Composition containing orotic acid, and process for production thereof
06/21/2012WO2012081531A1 Disease inhibiting agent
06/21/2012WO2012081273A1 Disease inhibiting agent
06/21/2012WO2012081227A1 Therapeutic agent for disc herniation
06/21/2012WO2012080333A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012WO2012079279A1 Pregnane glycoside compounds containing orthoester groups and use thereof
06/21/2012WO2012037083A3 Compositions and method for promoting musculoskeletal repair
06/21/2012WO2012031228A3 Llp2a-bisphosphonate conjugates for osteoporosis treatment
06/21/2012US20120157539 Nuclear receptor binding agents
06/21/2012US20120157523 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
06/21/2012US20120157502 Phenanthrenone compounds, compositions and methods
06/21/2012US20120157494 Isoindolyl compounds
06/21/2012US20120157481 Tricyclic pyrimidine derivatives as wnt antagonists
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157428 Bromodomain inhibitors and uses thereof
06/21/2012US20120157418 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157388 External composition for skin
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120156725 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
06/21/2012US20120156288 Microcapsules containing salts for food products
06/21/2012US20120156284 Enhanced biological autologous tissue adhesive composition and methods of preparation and use
06/21/2012US20120156276 Connective tissue stimulating peptides
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156209 Anti-il-tif antibodies and methods of use
06/21/2012US20120156207 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156192 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
06/21/2012US20120156177 Methods and devices for harvesting and processing connective tissue precursor cells from autologous fat
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012CA2821244A1 Therapeutic agent for disc herniation
06/21/2012CA2821219A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012CA2820871A1 Disease inhibiting agent
06/20/2012EP2465512A1 Pharmaceutical composition for suppressing pain
06/20/2012EP2464667A2 N-acylated octasaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464359A2 N-sulfated oligosaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464337A1 Pharmaceutical composition and administrations thereof
06/20/2012EP2464247A2 Nutritional supplements
06/20/2012EP2464232A1 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2303268B1 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use
06/20/2012EP2099815B1 Novel amides acting on the adenosine receptors
06/20/2012EP2075258B1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same
06/20/2012EP2021321B1 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
06/20/2012EP1496053B1 Kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative
06/20/2012CN1835766B Osteogenesis promoter
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504021A FBXL15 protein as well as inhibitor of FBXL15 protein and applications of FBXL15 protein and inhibitor
06/20/2012CN102503976A Alpha-quaternary carbon contained alpha, beta-diamino acid derivative, synthetic method thereof and application thereof
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102503932A Novel gas signal molecule donator and preparation method and use thereof
06/20/2012CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof
06/20/2012CN102499980A Application of polypeptides to preparation of medicament for treating or preventing rheumatoid arthritis
06/20/2012CN102499964A A traditional Chinese medicinal preparation for treating necrosis of femoral head
06/20/2012CN102499963A Traditional Chinese medicine compound for treating fracture
06/20/2012CN102499962A Traditional Chinese medicine for treating rheumatoid arthritis
06/20/2012CN102499960A Method for improving uniformity of strychnine in nux vomica powder of bone and tendon pill capsules
06/20/2012CN102499955A Oral decoction of Chinese herbal medicine
06/20/2012CN102499952A Preparation method of Zanthoxylum acanthopodium lignan substances
06/20/2012CN102499947A Traditional Chinese medicine preparation for treating bedsore and inflammatory pain around knee joint and preparation method thereof
06/20/2012CN102499934A Application of 3-methoxy xanthone compound in preparation of medicament for preventing and treating hyperuricemia
06/20/2012CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof
06/20/2012CN102499919A Medicine combination containing low sirolimus dose for treating or preventing fibrotic diseases
06/20/2012CN102499916A Application of 1 beta-hydroxy alantolactone in preparation of medicine for preventing and curing rheumatoid arthritis
06/20/2012CN102499915A Drug with Chinese rhubarb acid compound and preparation method of clathrate compound of Chinese rhubarb acid compound
06/20/2012CN102499379A Preparation technology for compound aquatic organism collagen peptide-calcium complex, technology for preparing calcium supplement from complex, and application of calcium supplement
06/20/2012CN101870734B Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
06/20/2012CN101773498B Preparation method of oral slow/controlled-release preparation containing febuxostat
06/20/2012CN101716277B Method for determining active ingredients of rhizoma smilacis glabrae medicinal material
06/20/2012CN101670010B Method for extracting flavonoid glycoside substance
06/20/2012CN101547922B Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
06/20/2012CN101332292B Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
06/19/2012US8202856 Triazole oxadiazoles derivatives
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2473694C Use of calmodulin to promote bone regeneration
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/17/2012CA2762080A1 Compositions comprising lilium siberia extracts and uses thereof
06/14/2012WO2012078734A2 Polypeptide derived from calcitonin receptors and methods of use
06/14/2012WO2012078593A2 Lysophosphatidic acid receptor antagonists and uses thereof
06/14/2012WO2012078504A1 TREATMENT OF CHRONIC INFLAMMATION WITH A 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVE
06/14/2012WO2012077828A1 Therapeutic agent for inflammatory diseases, which can inhibit function of inflammatory cytokine
06/14/2012WO2012076194A1 Combination preparations comprising a cytokine antagonist and corticosteroid
06/14/2012WO2012076193A1 Combination preparations comprising exosomes and corticosteroid
06/14/2012WO2012056478A8 Oxazoline and isoxazoline derivatives as crac modulators
06/14/2012WO2012050714A3 Cartilage oligomeric matrix protein (comp)-growth factor complexes and uses thereof
06/14/2012WO2011149310A9 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
06/14/2012US20120149778 Compounds
06/14/2012US20120149742 Heterocyclic derivatives as modulators of ion channels
06/14/2012US20120149740 Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
06/14/2012US20120149739 Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
06/14/2012US20120149736 Enzyme inhibitors
06/14/2012US20120149735 1,4-Dihydropyridine Derivatives and Their Uses
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 820